Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Wnt signaling pathway | R-HSA-195721 | map04310 | DL-thiorphan | 3132 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | DL-thiorphan | 3132 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | DL-thiorphan | 3132 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | DL-thiorphan | 3132 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | DL-thiorphan | 3132 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | DL-thiorphan | 3132 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | DL-thiorphan | 3132 | drug-path |
Nucleotide excision repair | R-HSA-5696398 | map03420 | pyridoxine | 3689 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pyridoxine | 3689 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | pyridoxine | 3689 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | pyridoxine | 3689 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | pyridoxine | 3689 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | dacarbazine | 5479537 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | dacarbazine | 5479537 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | dacarbazine | 5479537 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dacarbazine | 5479537 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | syrosingopine | 19518 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | syrosingopine | 19518 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | syrosingopine | 19518 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | syrosingopine | 19518 | drug-path |